相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance
Marina Raju et al.
LIFE SCIENCES (2021)
Albumin-Coated Mesoporous Silica Nanoparticles of Docetaxel: Preparation, Characterization, and Pharmacokinetic Evaluation
Deepti Pandita et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2021)
Lipid-Coated MCM-41 Mesoporous Silica Nanoparticles Loaded with Berberine Improved Inhibition of Acetylcholine Esterase and Amyloid Formation
Anurag Kumar Singh et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)
Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast
Jyotsana R. Madan et al.
DERMATOLOGIC THERAPY (2020)
Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting
Deepika Deepika et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Chitosan-Based Nanocarriers for Nose to Brain Delivery
Blessing Atim Aderibigbe et al.
APPLIED SCIENCES-BASEL (2019)
Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability
Sushama Talegaonkar et al.
AAPS PHARMSCITECH (2019)
Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study
Varsha Pokharkar et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Distribution of a model bioactive within solid lipid nanoparticles and nanostructured lipid carriers influences its loading efficiency and oxidative stability
Yuanjie Pan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses
Anam Khan et al.
MOLECULAR PHARMACEUTICS (2016)
Nanoneurotherapeutics approach intended for direct nose to brain delivery
Md Shadab et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Formulation by design-based proniosome for accentuated transdermal delivery of risperidone: in vitro characterization and in vivo pharmacokinetic study
Syed Sarim Imam et al.
DRUG DELIVERY (2015)
Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment
Sumeet Sood et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles
[Anonymous]
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2014)
Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment
Jike Song et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Intranasal Treatment of Central Nervous System Dysfunction in Humans
Colin D. Chapman et al.
PHARMACEUTICAL RESEARCH (2013)
Optimization Studies on Gastroretentive Floating System Using Response Surface Methodology
Rajendra Awasthi et al.
AAPS PHARMSCITECH (2012)
Intranasal delivery of biologics to the central nervous system
Jeffrey J. Lochhead et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases
Reinhard Gabathuler
CNS & Neurological Disorders-Drug Targets (2012)
Formulation and Evaluation of In Situ Gelling Systems for Intranasal Administration of Gastrodin
Zheng Cai et al.
AAPS PHARMSCITECH (2011)
Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: In vitro and in vivo studies
U. Seju et al.
ACTA BIOMATERIALIA (2011)
Intranasal Delivery to the Central Nervous System: Mechanisms and Experimental Considerations
Shyeilla V. Dhuria et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases
Thomas M. Barchet et al.
EXPERT OPINION ON DRUG DELIVERY (2009)
Identification, isolation and characterization of process-related impurities in Rizatriptan benzoate
T. Joseph Sunder Raj et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers
Fei Han et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2008)
Nasal Drug Delivery System-Factors Affecting and Applications
Kisan R. Jadhav et al.
CURRENT DRUG THERAPY (2007)
Study on brain targeting of raltitrexed following intranasal administration in rats
DX Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Migraine: Current concepts and emerging therapies
DK Arulmozhi et al.
VASCULAR PHARMACOLOGY (2005)
Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
RG Thorne et al.
NEUROSCIENCE (2004)
Nasal route and drug delivery systems
S Türker et al.
PHARMACY WORLD & SCIENCE (2004)
Profiles of methotrexate in blood and CSF following intranasal and intravenous administration to rats
F Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2003)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Vascular effects of 5-HT1B/1D-receptor agonists in patients with migraine headaches
JNJM de Hoon et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
